Tumor-induced immune dysfunction (original) (raw)

Abstract

Immune system-based approaches for the treatment of malignant disease over the past decades have often focused on cytolytic effector cells such as cytotoxic T lymphocytes (CTL), and natural killer (NK) cells. It has also been demonstrated that tumor-bearing mice can be cured using a wide variety of approaches, some of which involve cytokine-mediated enhancement of CTL and NK cell activity. However, the apparent success in mice stands in contrast to the current situation in the clinic, wherein only a minority of patients have thus far benefited from CTL- or NK cell-based antitumor approaches. The underlying causes of tumor-associated immune suppression of CTL and NK cell activity are discussed, and features of interest shared with HIV infection, leprosy, and rheumatoid arthritis are also be mentioned. Remarkable and very recent observations have shed more light upon the causes of dysfunctional alterations in CTL and NK cells often associated with these diseases, that in turn have suggested new immunotherapeutic approaches for cancer and infectious disease.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Cancer Center Karolinska, Immune- and Genetherapy Laboratory, KS-ringen R8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden e-mail: Rolf.Kiessling@mtc.ki.se; Fax: +46-8-309195, , , , , , SE
    Rolf Kiessling, Shigetoshi Horiguchi, Pavel Pisa & Max Petersson
  2. LMI, DBS, NCI-Frederick Cancer Research and Development Center, Bldg. 560, Frederick, MD 21702, USA, , , , , , US
    Ken Wasserman
  3. Yamanashi University Medical School, Department of Surgery, 1110 Shimogato, Tamaho-Cho, Nakagoma-Gun, Yamanashi-Ken, 409-38, Japan, , , , , , JP
    Koji Kono
  4. Department of Hematology and Infectious Diseases, Karolinska Hospital, S-171 76 Stockholm, Sweden, , , , , , SE
    Jan Sjöberg

Authors

  1. Rolf Kiessling
    You can also search for this author inPubMed Google Scholar
  2. Ken Wasserman
    You can also search for this author inPubMed Google Scholar
  3. Shigetoshi Horiguchi
    You can also search for this author inPubMed Google Scholar
  4. Koji Kono
    You can also search for this author inPubMed Google Scholar
  5. Jan Sjöberg
    You can also search for this author inPubMed Google Scholar
  6. Pavel Pisa
    You can also search for this author inPubMed Google Scholar

Additional information

Received: 20 March 1999 / Accepted: 3 May 1999

Rights and permissions

About this article

Cite this article

Kiessling, R., Wasserman, K., Horiguchi, S. et al. Tumor-induced immune dysfunction.Cancer Immunol Immunother 48, 353–362 (1999). https://doi.org/10.1007/s002620050586

Download citation